iMediSync

What iMediSync does

iMediSync is an AI-based digital mental health technology company founded in Seoul, South Korea in 2012, with a North American subsidiary headquartered in Aliso Viejo, California. The company has built an integrated platform that combines dry-electrode wireless EEG hardware with automated EEG and HRV analytics, powered by what it describes as the world's largest sex-classified QEEG normative database covering 1,300+ healthy individuals aged 4 to 82. The platform targets clinicians, mental health providers, medical centers, and academic researchers who need objective physiological biomarkers for mental health, cognitive decline, and concussion assessment.

The core product ecosystem comprises iSyncWave and iSyncMe (gel-free, Bluetooth-enabled 19-channel EEG headsets following the international 10/20 placement standard), iSyncBrain (a cloud-based AI analysis platform generating QEEG and HRV reports in approximately 10 minutes), iSyncHeart (an integrated PPG-based HRV module for autonomic nervous system assessment), and BrainBoost Neurofeedback (a gamified brainwave-controlled training platform). iSyncWave is FDA 510(k) cleared as a Class II medical device, CE Mark certified, and the underlying software is KFDA approved with ISO 13485, HIPAA, and GDPR compliance. The 2024 launches of iSyncBrain, iSyncHeart, and BrainBoost represent the company's most recent product expansion phase. Note that the PBM Therapy and aMCI classifier are explicitly NOT FDA cleared or approved and are positioned for research or investigational use only.

The company operates a direct enterprise sales model with quote-based pricing, personalized 30-minute product demos, and multi-year contracts. Revenue is generated through hardware sales of EEG devices, recurring software subscriptions across M Series (medical), Clinical Series, and Research Series tiers, and regulatory-cleared licensing across multiple jurisdictions. Distribution is handled through the North American subsidiary for the Americas region, with a dedicated international business development function building a Latin American distributor network. The company has a small leadership team of approximately 14 employees, with no public funding rounds or revenue figures disclosed.

Name

iMediSync

Legal name

iMediSync, Inc.

Website

https://imedisyncamericas.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

iMediSync is an AI-based digital mental health platform that combines FDA-cleared wireless EEG and HRV hardware with cloud-based QEEG analysis software and a proprietary sex-classified normative database, serving clinicians, mental health providers, and researchers in North America and Latin America.

Ownership category

akta.pro rank

Product category

Quantitative EEG Medical Devices

NAICS

Offices of Physicians, Mental Health Specialists (621112), Offices of Mental Health Practitioners (except Physicians) (621330)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Services-Prepackaged Software (7372)

akta.pro primary industry

Psychiatry & Medication Management Platforms (HLALAEAB)

akta.pro secondary industries

Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching) (HLALAEAJ), Integrated Behavioral Health (Collaborative Care) Platforms (HLALAEAC)

Keywords

• Quantitative EEG analysis
• Dry electrode EEG
• HRV monitoring
• AI mental health platform
• Photobiomodulation therapy

Headquarters

HQ city

Aliso Viejo

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain, Others

Revenue model

1. EEG Hardware Devices: Sale of iSyncWave and iSyncMe wireless EEG hardware devices with embedded PBM therapy capabilities. Devices are Class II medical devices sold to healthcare providers and clinicians.
2. Software Subscriptions (iSyncBrain): Cloud-based AI analysis platform providing QEEG reports, normative comparisons, and HRV analytics. Available in M Series (medical), Clinical Series, and Research Series tiers for different use cases.
3. Regulatory-Cleared Solutions: FDA 510(k) cleared EEG recording and analysis solutions for clinical use. CE Mark and KFDA approvals enable multi-regional revenue streams.

Pricing tiers

Distribution channels3 records

Marketing channels7 records

Core offering

iMediSync sells an integrated AI mental health care platform consisting of gel-free, wireless 19-channel EEG headsets (iSyncWave, iSyncMe) connected to a cloud-based AI analysis platform (iSyncBrain) that produces QEEG brain maps and HRV reports in 10 minutes, plus an integrated HRV module (iSyncHeart) and gamified neurofeedback (BrainBoost). The offering is sold primarily to clinicians, mental health providers, hospitals, and research institutions as a clinical decision-support system for mental health, cognitive decline, concussion, and peak performance applications.

Product overview

iMediSync is an integrated AI mental health care platform consisting of three core hardware and software products. The iSyncWave and iSyncMe are gel-free, wireless 19-channel EEG headsets (FDA 510(k) cleared for iSyncWave) that capture brain electrical activity. These connect to iSyncBrain, a cloud-based AI analysis platform with the world's largest sex-classified QEEG normative database (1,300+ individuals). iSyncHeart provides simultaneous HRV monitoring via integrated PPG sensor for autonomic nervous system assessment. The ecosystem includes optional PBM (Photobiomodulation) near-infrared light therapy integrated into iSyncWave, and BrainBoost Neurofeedback for gamified brain training. iSyncBrain is available in three series: M Series (medical grade with aMCI screening), Clinical Series (for private practices), and Research Series (for academic institutions).

Differentiator

Problem solved

Functional benefit

Brands

• iSyncWave: Gel-free, wireless EEG headset with 19 channels for rapid brain scanning and QEEG analysis.
• iSyncBrain
• iSyncHeart
• BrainBoost Neurofeedback

Products and services

• iSyncWave EEG Headset Gel-free, wireless 19-channel EEG headset following the international 10/20 electrode placement standard. FDA 510(k) cleared (K212345) Class II medical device for EEG recording and analysis, with integrated near-infrared PBM therapy for activating mitochondria and microglia activity. Connects to iSyncBrain cloud platform for QEEG analysis and HRV reports in 10 minutes. Sold to clinicians, hospitals, and medical centers.
• iSyncMe EEG Headset Gel-free, wireless EEG headset similar to iSyncWave, designed for rapid deployment and patient comfort as part of the iSyncBrain platform ecosystem. Connects to the cloud-based iSyncBrain platform to deliver QEEG and HRV analysis in 10 minutes.
• iSyncBrain AI Analysis Platform Cloud-based AI analysis platform that processes raw EEG data into actionable clinical insights and brain maps. Uses auto-denoising, AMICA, and sLORETA algorithms to generate comprehensive QEEG reports in 10 minutes, comparing patients against the world's largest sex-classified normative database. Available in M Series (medical grade with aMCI screening), Clinical Series (private practices), and Research Series (academic institutions). FDA Registered Clinical Decision Support Software; KFDA Approved Class II Medical Device Software.
• iSyncHeart HRV Analysis Module Integrated Heart Rate Variability (HRV) monitoring module using a PPG sensor to capture heart rhythm data simultaneously with EEG during a single session. Provides autonomic nervous system balance assessment, five-stage AI stress classification (89% accuracy in young adults), and proprietary depression (83% accuracy, 91% PPV) and anxiety (81% accuracy) screening models. Sold to clinicians for integrated brain-body assessment.
• BrainBoost Neurofeedback Gamified neurofeedback training platform that transforms traditional neurofeedback into interactive games controlled by brainwaves. Compatible with all iSync EEG devices (iSyncWave and iSyncMe) for improved focus, enhanced relaxation, and better mental performance. Distributed and integrated as part of iMediSync's comprehensive brain health ecosystem.

Quantifiable outcome

• 10-minute QEEG and HRV report generation from cloud-based analysis
• +4 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability7 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• BrainBoostcoreTechnology or IntegrationBrainBoost neurofeedback platform is fully integrated with iMediSync EEG devices (iSyncWave and iSyncMe). The partnership enables gamified neurofeedback training where patients control gameplay directly with their brainwaves. iMediSync distributes and integrates BrainBoost's BrainAssistant software as part of its comprehensive brain health ecosystem.
• IQPA (International Quantum Pulse Association)coreStrategic or Co-development PartnerIQPA education community provides clinical education and case review series for iMediSync users. Dr. Kim leads recurring case reviews focused on PBM cases, discussing real clinical outcomes. The partnership supports clinical training and peer learning within the iMediSync user community.
• iSyncSessions Clinical Education PlatformcoreStrategic or Co-development PartnerMonthly case conference series where QEEG guides precision PBM treatment. Clinicians review anonymized QEEG cases, discuss intervention strategies, and evaluate outcomes together. Structured format from signal analysis through intervention planning to outcome evaluation.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Emotiv: Emotiv offers consumer and research EEG headsets with cloud-based analytics, partially overlapping with iMediSync's EEG-data-to-insights workflow, particularly in research, wellness, and peak-performance segments.
• Akili Interactive: Akili builds FDA-cleared digital therapeutics for ADHD and other cognitive conditions — adjacent to iMediSync's ADHD use case but as a software-based intervention rather than an EEG-based assessment platform.
• Muse (Interaxon): Muse sells consumer EEG headbands for meditation, focus, and sleep — adjacent to iMediSync's wellness and peak-performance use cases, though it targets end-consumers rather than clinicians with full QEEG analytics.

Direct peers

• Advanced Brain Monitoring: Advanced Brain Monitoring provides clinical EEG and sleep/performance brain monitoring solutions to clinicians and researchers, directly competing in the same QEEG and brain-function assessment workflows as iMediSync.
• Mitsar: Mitsar manufactures clinical EEG and QEEG hardware and software suites for psychiatrists and neurologists, offering comparable EEG recording, normative comparison, and neurofeedback capabilities to iMediSync.
• Wearable Sensing: Wearable Sensing develops dry-electrode wireless EEG headsets for research and clinical use, overlapping with iMediSync's gel-free iSyncWave/iSyncMe value proposition in mobility and ease-of-deployment.
• ANT Neuro: ANT Neuro is a long-standing clinical EEG systems vendor for hospitals and research institutions, competing with iMediSync's iSyncWave hardware and iSyncBrain analysis software in the clinical neurodiagnostics market.
• BrainMaster Technologies: BrainMaster sells clinical QEEG/EEG systems and neurofeedback hardware used by mental health and neurology clinicians — a direct competitor in the clinical EEG assessment category that iMediSync targets.
• Cognionics (CGX): Cognionics (formerly CGX) makes dry-electrode EEG headset systems for clinical and research applications, directly competing on the wireless dry-EEG hardware differentiator that anchors iMediSync's clinical workflow.

Broad incumbents

• Natus Medical: Natus Medical is an established neurodiagnostics incumbent supplying EEG, EMG, and sleep-monitoring equipment to hospitals worldwide — a broad incumbent competing with iMediSync in clinical EEG procurement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/imedisyncusers
• LinkedInlinkedin.com/company/imedisync

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iMediSync